Magnetic separation of lipoproteins using dextran sulfate

US10308680B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10308680-B2
Application numberUS-201514985632-A
CountryUS
Kind codeB2
Filing dateDec 31, 2015
Priority dateDec 30, 2010
Publication dateJun 4, 2019
Grant dateJun 4, 2019

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The invention provides apparatus and methods of preparation of lipoproteins from a biological sample, including HDL, LDL, Lp(a), IDL, and VLDL, for diagnostic purposes utilizing differential charged-particle mobility analysis methods. Further provided are methods for analyzing the size distribution of lipoproteins by differential charged-particle mobility, which lipoproteins are prepared by methods of the invention. Further provided are methods for assessing lipid-related health risk, cardiovascular condition, risk of cardiovascular disease, and responsiveness to a therapeutic intervention, which methods utilize lipoprotein size distributions determined by methods of the invention.

First claim

Opening claim text (preview).

What is claimed is: 1. A method for purifying lipoproteins suitable for differential charged-particle mobility analysis of lipoprotein class and subclass, said method not including density gradient centrifugation; said method comprising: combining glycine with a sample comprising lipoproteins to provide a glycine mixture; adding one or more cations and dextran sulfate to the glycine mixture to form a precipitation mixture; contacting the precipitation mixture with an insoluble solid support, wherein one or more classes or subclasses of lipoproteins from said sample precipitate from said mixture to form precipitated lipoproteins onto said insoluble solid support; separating said precipitated lipoproteins on said insoluble solid support from said mixture; and removing said precipitated lipoproteins from said insoluble solid support; wherein said precipitated lipoproteins on said insoluble solid support comprise HDL and one or more selected from the group consisting of LDL, Lp(a), IDL and VLDL; wherein said insoluble solid support comprises magnetic beads and binds precipitated lipoproteins without an immunoaffinity agent; and wherein said dextran sulfate is not biotinylated and said precipitated lipoproteins are not bound to said insoluble solid support by streptavidin. 2. The method of claim 1 , wherein said cations comprise one or more divalent cations. 3. The method of claim 2 , wherein said one or more divalent cations are selected from the group consisting of Mg 2+ , Ca 2+ , Mn 2+ , and Sr 2+ . 4. The method of claim 2 , wherein said one or more divalent cations comprise Ca 2+ . 5. The method of claim 4 , wherein said precipitation mixture comprises Ca 2+ at a concentration within the range of about 25 mM to about 200 mM. 6. The method of claim 4 , wherein said precipitation mixture comprises Ca 2+ at a concentration of about 150 mM. 7. The method of claim 2 , wherein said one or more divalent cations comprise Mg 2+ . 8. The method of claim 7 , wherein said precipitation mixture comprises Mg 2+ at a concentration within the range of about 25 mM to about 200 mM. 9. The method of claim 7 , wherein said precipitation mixture comprises Mg 2+ at a concentration of about 100 mM. 10. The method of claim 2 , wherein said one or more divalent cations comprise Ca 2+ and Mg 2+ . 11. The method of claim 10 , wherein said precipitation mixture comprises Ca 2+ at a concentration within the range of about 25 mM to about 200 mM and Mg 2+ at a concentration within the range of about 25 mM to about 200 mM. 12. The method of claim 10 , wherein said precipitation mixture comprises Ca 2+ at a concentration of about 25 mM and Mg 2+ at a concentration of about 100 mM. 13. The method of claim 1 , wherein said dextran sulfate is in the size range of about 10 to about 500 kDa. 14. The method of claim 1 , wherein said dextran sulfate is in the size range of about 50 to about 100 kDa. 15. The method of claim 1 , wherein said dextran sulfate has a size of about 50 kDa. 16. The method of claim 1 , wherein the magnetic beads comprise a magnetic or paramagnetic core.

Assignees

Inventors

Classifications

  • using electrophoresis · CPC title

  • Ion mobility spectrometry · CPC title

  • Hydrolysis with acids different from HF · CPC title

  • C07K1/30Primary

    by precipitation · CPC title

  • by a combination of two or more processes of different types · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10308680B2 cover?
The invention provides apparatus and methods of preparation of lipoproteins from a biological sample, including HDL, LDL, Lp(a), IDL, and VLDL, for diagnostic purposes utilizing differential charged-particle mobility analysis methods. Further provided are methods for analyzing the size distribution of lipoproteins by differential charged-particle mobility, which lipoproteins are prepared by met…
Who is the assignee on this patent?
Quest Diagnostics Invest Inc
What technology area does this patent fall under?
Primary CPC classification C07K1/30. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Jun 04 2019 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).